Molecule
- Sitagliptin (100 mg): A DPP-4 inhibitor that increases incretin hormone levels, improving insulin secretion and reducing blood sugar levels.
- Dapagliflozin 10 mg: Dapagliflozin is a SGLT2 inhibitor that lowers blood sugar by causing the kidneys to get rid of more glucose in the urine.
Category
Antidiabetic & Cardiovascular – DPP-4 Inhibitor + SGLT2 Inhibitor.
Sitagliptin 100 mg + Dapagliflozin 10 mg.
Sitalor D 100/10 is a dual-action formulation combining Sitagliptin (100 mg) and Dapagliflozin (10 mg). Both are antidiabetic agents that work by different mechanisms to lower blood sugar levels, Dapagliflozin increases urinary glucose excretion while sitagliptin enhances insulin release and reduces glucogon secretion.
Benefits
Improves insulin sensitivity and glycemic control Reduces fasting and postprandial blood sugar levels Enhances pancreatic beta-cell function
Storage & Precautions
- Store below 30°C in a dry place
- Not for patients with severe kidney or liver conditions
- Avoid alcohol consumption.
Packaging
10 x 10 Tablets per box
For medical use only. Consult a doctor before use.